E. Fuseau

发表

Mixed Effect Modeling of Sumatriptan Pharmacokinetics During Drug Development: II. From Healthy Subjects to Phase 2 Dose Ranging in Patients

V. Cosson, E. Fuseau, 1999, Journal of Pharmacokinetics and Biopharmaceutics.

Pharmacokinetics and safety of roledumab, a novel human recombinant monoclonal anti‐RhD antibody with an optimized Fc for improved engagement of FCγRIII, in healthy volunteers

J. Prost, F. Dhainaut, R. Béliard, 2012, Vox sanguinis.

First in man study of EP217609, a new long-acting, neutralisable parenteral antithrombotic with a dual mechanism of action

M. Petitou, E. Fuseau, P. V. van Giersbergen, 2016, European Journal of Clinical Pharmacology.

Neutralization of EP217609, a new dual-action FIIa/FXa anticoagulant, by its specific antidote avidin: a phase I study

M. Petitou, E. Fuseau, P. Giersbergen, 2016, European Journal of Clinical Pharmacology.

EP42675, a synthetic parenteral dual‐action anticoagulant: pharmacokinetics, pharmacodynamics, and absence of interactions with antiplatelet drugs

M. Petitou, E. Fuseau, P. Giersbergen, 2014, Journal of thrombosis and haemostasis : JTH.

Challenges in collecting pharmacokinetic and pharmacodynamic information in an intensive care setting: PK/PD modelling of clazosentan in patients with aneurysmal subarachnoid haemorrhage

J. Zisowsky, J. Dingemanse, A. Krause, 2014, European Journal of Clinical Pharmacology.

Rufinamide: Clinical pharmacokinetics and concentration–response relationships in patients with epilepsy

E. Perucca, J. Cloyd, E. Fuseau, 2008, Epilepsia.

Combined Low-Dose Acetylsalicylic Acid and Dihydroergotamine in Migraine Prophylaxis: A Double-Blind, Placebo-Controlled Crossover Study

M. Bousser, E. Fuseau, T. Soisson, 1988, Cephalalgia : an international journal of headache.

Pharmacodynamics and pharmacokinetics of mizolastine (SL 85.0324), a new nonsedative H1 antihistamine.

P. Rosenzweig, G. Bianchetti, P. Morselli, 1992, Annals of allergy.

Reduction of hyperglycemia after oral glucose load by the new α2‐adrenergic receptor antagonist SL 84.0418 in healthy subjects

A. Puech, P. Rosenzweig, I. Berlin, 1994, Clinical pharmacology and therapeutics.

Population Models for Drug Absorption and Enterohepatic Recycling

V. Cosson, E. Fuseau, M. Marchand, 2006 .

A Population Pharmacokinetic–Pharmacodynamic Analysis of Repeated Measures Time-to-Event Pharmacodynamic Responses: The Antiemetic Effect of Ondansetron

Lewis B. Sheiner, Stuart L. Beal, L. Sheiner, 1999, Journal of Pharmacokinetics and Biopharmaceutics.

Comparative clinical pharmacokinetics of single doses of sumatriptan following subcutaneous, oral, rectal and intranasal administration.

E. Fuseau, J. Mamet, C. Duquesnoy, 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Safety, Tolerability, and Pharmacokinetics of Sumatriptan in Healthy Subjects Following Ascending Single Intranasal Doses and Multiple Intranasal Doses

E. Fuseau, S. Shaw, C. Duquesnoy, 1997, Cephalalgia : an international journal of headache.

Population Pharmacokinetics of Onercept in Healthy Subjects

E. Fuseau, Q. Nguyen, S. Glatt, 2005, Clinical pharmacokinetics.

Simultaneous Modeling of Pharmacokinetics and Pharmacodynamics with a Nonparametric Pharmacodynamic Model

L B Sheiner, L. Sheiner, E Fuseau, 1984, Clinical pharmacology and therapeutics.

[Pharmacokinetic and clinical investigation of amoxicillin administered intravenously in the newborn ].

M. Rodière, E. Fuseau, J. Kassis, 1982, Pathologie-biologie.

Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients

V. Cosson, E. Fuseau, E. S. Desoky, 2003, European Journal of Clinical Pharmacology.

Pharmacokinetics of Sumatriptan Nasal Spray in Children

M. Christensen, J. Jabbour, E. Fuseau, 2004, Journal of clinical pharmacology.

Effect of encapsulation on absorption of sumatriptan tablets: data from healthy volunteers and patients during a migraine.

A. Metz, E. Fuseau, R. Salonen, 2001, Clinical therapeutics.

Mixed Effect Modeling of Sumatriptan Pharmacokinetics During Drug Development. I: Interspecies Allometric Scaling

V. Cosson, C. Efthymiopoulos, A. Bye, 1997, Journal of Pharmacokinetics and Biopharmaceutics.

Pharmacokinetics of Sumatriptan Nasal Spray in Adolescents

M. Christensen, J. Jabbour, E. Fuseau, 2003, Journal of clinical pharmacology.

Early clinical experience with subcutaneous naratriptan in the acute treatment of migraine: a dose‐ranging study

J. Olesen, H. Petit, J. Schoenen, 1998, European journal of neurology.

Modeling and Simulation for Clinical Trial Design Involving a Categorical Response: A Phase II Case Study with Naratriptan

Stephen Duffull, Leon Aarons, Ivan Nestorov, 2001, Pharmaceutical Research.

Population pharmacokinetics of a triple‐secured fibrinogen concentrate administered to afibrinogenaemic patients: Observed age‐ and body weight‐related differences and consequences for dose adjustment in children

A. Bellon, E. Fuseau, C. Henriet, 2020, British journal of clinical pharmacology.

Population Pharmacokinetics of Oral Risperidone in Children, Adolescents and Adults with Psychiatric Disorders

A. Vermeulen, E. Mannaert, E. Fuseau, 2010, Clinical pharmacokinetics.

Clinical Pharmacokinetics of Intranasal Sumatriptan

E. Fuseau, K. Moore, A. Barrow, 2002, Clinical pharmacokinetics.

Cns Effects of Sumatriptan and Rizatriptan in Healthy Female Volunteers

R. Schoemaker, J. V. van Gerven, E. Fuseau, 2002, Cephalalgia : an international journal of headache.

Plasma and skin suction-blister-fluid pharmacokinetics and time course of the effects of oral mizolastine

P. Rosenzweig, G. Bianchetti, E. Espagne, 1996, European Journal of Clinical Pharmacology.

1-21-09 Naratriptan oral pharmacokinetics in migraine subjects

M. Asgharnejad, E. Fuseau, C. Huffman, 1997, Journal of the Neurological Sciences.

Supporting the recommended paediatric dosing regimen for rufinamide in Lennox–Gastaut syndrome using clinical trial simulation

E. Fuseau, M. Marchand, D. Critchley, 2010, Journal of Pharmacokinetics and Pharmacodynamics.

Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modeling.

Eliane Fuseau, H. Ficheux, E. Fuseau, 2007, Journal of pharmaceutical sciences.

Pharmacokinetics, Drug Interactions and Exposure-Response Relationship of Eslicarbazepine Acetate in Adult Patients with Partial-Onset Seizures

A. Falcão, P. Soares-da-Silva, E. Fuseau, 2012, CNS Drugs.

Meta‐Analysis of The Exposure/Efficacy Relationship for Sumatriptan Nasal Spray

E. Fuseau, O. Pétricoul, 1999 .

Effects of zolpidem versus diazepam and placebo on breathing control parameters in healthy human subjects.

P. Rosenzweig, D. Maillard, J. Thiercelin, 1992, International journal of clinical pharmacology research.